Strand Therapeutics


Overview

Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapeutics that are capable of making autonomous decisions, they sought to apply the world's first synthetic biology platform for mRNA therapeutics. This area was untapped by traditional synthetic biology, which led them to build their own mRNA “programming language,” creating the world’s first platform for mRNA smart immunotherapies.

Video Pitch


Management Team

Jacob Becraft